4//SEC Filing
Vizirgianakis Stavros G. 4
Accession 0001493152-24-031316
CIK 0000719135other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:50 PM ET
Size
6.0 KB
Accession
0001493152-24-031316
Insider Transaction Report
Form 4
Vizirgianakis Stavros G.
Director
Transactions
- Award
Stock Option (Option to Buy)
2024-08-08−17,000→ 17,000 totalExercise: $1.02From: 2024-08-08Exp: 2034-08-08→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.
Documents
Issuer
Apyx Medical Corp
CIK 0000719135
Entity typeother
Related Parties
1- filerCIK 0001559834
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:50 PM ET
- Size
- 6.0 KB